Moving closer to reality

Medicinal cannabis is one step closer to becoming a reality, with a proposal to allow its restricted use added to the agenda for the March 2016 meeting of the Advisory Committee on Medicines Scheduling.

The proposal would allow “appropriate access to medicinal cannabis products” by creating new Schedule 8 entries for the following substances for internal human therapeutic use:

  • Cannabis (plant and flowering tops)
  • Botanically derived extracts (or derivatives) of cannabis
  • Tetrahydrocannabinols, where they are botanically derived from cannabis

The proposal would